Suven Pharmaceuticals Limited (SUVENPHAR) — Financial Flexibility Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Financial Flexibility Index of 0.33x as of December 2023. Free cash flow of Rs255.04 Million (operating CF Rs255.04 Million minus capex Rs0.00) represents 0% of total liabilities (Rs765.00 Million). Check SUVENPHAR capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Suven Pharmaceuticals Limited Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Suven Pharmaceuticals Limited across 7 annual periods. See Suven Pharmaceuticals Limited (SUVENPHAR) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year free cash flow to debt coverage for Suven Pharmaceuticals Limited. For the full company profile including market capitalisation, see Suven Pharmaceuticals Limited (SUVENPHAR) total market value.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | Rs4.44 Billion | Rs2.88 Billion | Rs11.91 Billion | ▼ -81.5% |
| 2024 | 2.02x | Rs4.10 Billion | Rs3.58 Billion | Rs2.03 Billion | ▼ -36.9% |
| 2023 | 3.20x | Rs7.37 Billion | Rs4.51 Billion | Rs2.31 Billion | ▲ +138.5% |
| 2022 | 1.34x | Rs4.05 Billion | Rs3.30 Billion | Rs3.02 Billion | ▼ -20.4% |
| 2021 | 1.68x | Rs4.94 Billion | Rs3.83 Billion | Rs2.94 Billion | ▲ +7.1% |
| 2020 | 1.57x | Rs5.15 Billion | Rs4.16 Billion | Rs3.28 Billion | ▲ +182.5% |
| 2019 | 0.56x | Rs1.07 Billion | Rs504.05 Million | Rs1.93 Billion | — |